This case report demonstrates long-term survival (37 months) in a rare case of left atrial myxosarcoma with systemic metastasis treated with a multimodal approach including surgery, chemotherapy, and stem cell transplantation.
Answers are grounded in this paper and cite their sources.
Supports multimodal therapy consideration in rare metastatic myxosarcoma; single-case evidence leaves generalizability open.
The term myxosarcoma is currently not used in standard classification for soft tissue tumors, but restricted to cardiac tumors. Primary cardiac myxosarcoma is a very rare disease and is difficult to differentiate from myxoma clinically and pathologically. We report a case of left atrial myxosarcoma with widespread systemic metastasis in a 21-yr-old male. The patient presented with sudden onset of intermittent dyspnea and orthopnea. Echocardiography showed a mobile, pedunculated tumor, 7.5x5x2 cm in size, at left atrium. Histologically, the excised tumor showed an amorphous finely fibrillar and mucinous stroma, in which irregular cords and clusters of lepidic cells and large stellate cells with plump vesicular nuclei resembled the usual type of cardiac myxoma were noted. And it showed focally cellular area with great nuclear pleomorphism and frequent mitoses. The patient received combination chemotherapy, peripheral blood stem cell collection transplantation and operations for systemic metastases in the brain, skeletal muscle and lung. He is alive at present 37 months after initial diagnosis and has no more new metastatic lesion.
No takes yet. Share an insight, caveat, or question.
Roh et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: